Inventor · disambiguated record
Andres Lopez-Albaitero
Also filed as: LOPEZ-ALBAITERO ANDRES
7 granted patents·1 pending application·20 citations·filing 2010–2021
79Inventor score
Top patents by PatentIndex Score
8 records- 0190US10519248B2Bispecific HER2 and CD3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Dec 31, 2019·10 cites·20 claims
- 0289US11046768B2Bispecific HER2 and CD3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jun 29, 2021·5 cites·15 claims
- 0385US11820832B2Bispecific HER2 and CD3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Nov 21, 2023·2 cites·12 claims
- 0474US11987642B2Bispecific HER2 and CD3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted May 21, 2024·0 cites·10 claims
- 0566US8367069B2Cytotoxic T cell defined EGFR peptide and an optimized derivative peptideUNIV PITTSBURGH·Filed 2010·Granted Feb 5, 2013·3 cites·10 claims
- 0663US2021324079A1Bispecific her2 and cd3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 0762US11168150B2T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLAMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Nov 9, 2021·0 cites·16 claims
- 0846US10501559B2T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLAMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Dec 10, 2019·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Andres Lopez-Albaitero files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →